Ipsita Agarwal

Ipsita Agarwal

Auto-generated profile, based on publicly available information

Ipsita Agarwal

Department of Biological Sciences, Columbia University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in eLife
Verified
Journal Article
Open access
HMHakhamanesh Mostafavi
Hakhamanesh Mostafavi
AHArbel Harpak
Arbel Harpak
IAIpsita Agarwal
Ipsita Agarwal
DCDalton Conley
Dalton Conley
JPJonathan K Pritchard
Jonathan K Pritchard
MPMolly Przeworski
Molly Przeworski
Fields as diverse as human genetics and sociology are increasingly using polygenic scores based on genome-wide association studies (GWAS) for phenotypic prediction. However, recent work has shown that polygenic scores have limited portability across groups of different genetic ancestries, restricting the contexts in which they can be used reliably and potentially creating serious inequities in future clinical applications. Using the UK Biobank data, we demonstrate that even within a single ancestry group (i.e., when there are negligible differences in linkage disequilibrium or in causal alleles frequencies), the prediction accuracy of polygenic scores can depend on characteristics such as the socio-economic status, age or sex of the individuals in which the GWAS and the prediction were conducted, as well as on the GWAS design. Our findings highlight both the complexities of interpreting polygenic scores and underappreciated obstacles to their broad use.

17 January 2023 in eLife
Verified
Journal Article
Open access
IAIpsita Agarwal
Ipsita Agarwal
ZFZachary L Fuller
Zachary L Fuller
SMSimon R Myers
Simon R Myers
MPMolly Przeworski
Molly Przeworski
Causal loss-of-function (LOF) variants for Mendelian and severe complex diseases are enriched in 'mutation intolerant' genes. We show how such observations can be interpreted in light of a model of mutation-selection balance and use the model to relate the pathogenic consequences of LOF mutations at present to their evolutionary fitness effects. To this end, we first infer posterior distributions for the fitness costs of LOF mutations in 17,318 autosomal and 679 X-linked genes from exome sequences in 56,855 individuals. Estimated fitness costs for the loss of a gene copy are typically above 1%; they tend to be largest for X-linked genes, whether or not they have a Y homolog, followed by autosomal genes and genes in the pseudoautosomal region. We compare inferred fitness effects for all possible de novo LOF mutations to those of de novo mutations identified in individuals diagnosed with one of six severe, complex diseases or developmental disorders. Probands carry an excess of mutations with estimated fitness effects above 10%; as we show by simulation, when sampled in the population, such highly deleterious mutations are typically only a couple of generations old. Moreover, the proportion of highly deleterious mutations carried by probands reflects the typical age of onset of the disease. The study design also has a discernible influence: a greater proportion of highly deleterious mutations is detected in pedigree than case-control studies, and for autism, in simplex than multiplex families and in female versus male probands. Thus, anchoring observations in human genetics to a population genetic model allows us to learn about the fitness effects of mutations identified by different mapping strategies and for different traits.

19 August 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
IAIpsita Agarwal
Ipsita Agarwal
MPMolly Przeworski
Molly Przeworski
Significance: Germline mutations, the accidental changes to the genome that occur during gametogenesis, are the source of all heritable variation. Because they are difficult to study directly, however, their determinants remain poorly understood. We use rare human polymorphisms in large samples as proxies for de novo mutations and compare mutational patterns across regions of the X chromosome and autosomes with unique biochemical and sex-specific properties. We highlight signatures of replication timing and repair of meiotic double-strand breaks and show how these biochemical processes may interact with sex-specific life history traits to shape the mutation spectrum. Our analysis has implications for understanding mutation rate variation along the genome, interpreting differences on the X and autosomes, and for the evolution of mutation rates.

22 November 2021 in eLife
Verified
Journal Article
Open access
IAIpsita Agarwal
Ipsita Agarwal
MPMolly Przeworski
Molly Przeworski
Whole exome sequences have now been collected for millions of humans, with the related goals of identifying pathogenic mutations in patients and establishing reference repositories of data from unaffected individuals. As a result, we are approaching an important limit, in which datasets are large enough that, in the absence of natural selection, every highly mutable site will have experienced at least one mutation in the genealogical history of the sample. Here, we focus on CpG sites that are methylated in the germline and experience mutations to T at an elevated rate of ~10-7 per site per generation; considering synonymous mutations in a sample of 390,000 individuals, ~ 99 % of such CpG sites harbor a C/T polymorphism. Methylated CpG sites provide a natural mutation saturation experiment for fitness effects: as we show, at current sample sizes, not seeing a non-synonymous polymorphism is indicative of strong selection against that mutation. We rely on this idea in order to directly identify a subset of CpG transitions that are likely to be highly deleterious, including ~27 % of possible loss-of-function mutations, and up to 20 % of possible missense mutations, depending on the type of functional site in which they occur. Unlike methylated CpGs, most mutation types, with rates on the order of 10-8 or 10-9, remain very far from saturation. We discuss what these findings imply for interpreting the potential clinical relevance of mutations from their presence or absence in reference databases and for inferences about the fitness effects of new mutations.

5 September 2017 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
WJWeston J. Jackson
Weston J. Jackson
IAIpsita Agarwal
Ipsita Agarwal
IPItsik Pe’er
Itsik Pe’er
Motivation. Microbiome sequencing allows defining clusters of samples with shared composition. However, this paradigm poorly accounts for samples whose composition is a mixture of cluster-characterizing ones and which therefore lie in between them in the cluster space. This paper addresses unsupervised learning of 2-way clusters. It defines a mixture model that allows 2-way cluster assignment and describes a variant of generalized k-means for learning such a model. We demonstrate applicability to microbial 16S rDNA sequencing data from the Human Vaginal Microbiome Project.

15 January 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
IAIpsita Agarwal
Ipsita Agarwal
MPMolly Przeworski
Molly Przeworski
The sources of human germline mutations are poorly understood. Part of the difficulty is that mutations occur very rarely, and so direct pedigree-based approaches remain limited in the numbers that they can examine. To address this problem, we consider the spectrum of low frequency variants in a dataset (gnomAD) of 13,860 human X chromosomes and autosomes. X-autosome differences are reflective of germline sex differences, and have been used extensively to learn about male versus female mutational processes; what is less appreciated is that they also reflect chromosome-level biochemical features that differ between the X and autosomes. We tease these components apart by comparing the mutation spectrum in multiple genomic compartments on the autosomes and between the X and autosomes. In so doing, we are able to ascribe specific mutation patterns to replication timing and recombination, and to identify differences in the types of mutations that accrue in males and females. In particular, we identify C>G as a mutagenic signature of male meiotic double strand breaks on the X, which may result from late repair. Our results show how biochemical processes of damage and repair in the germline interact with sex-specific life history traits to shape mutation patterns on both the X chromosome and autosomes.